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ABSTRACT 
Hypertension is one of the long term medical problems in world leading to mortality of 18% globally. Epigenetic modifications like 
gene regulation, DNA histone modification and methylation patterns are mostly affected during Hypertension condition and need to 
be carefully monitored. So, metosartan is the one of the antihypertensive drug used to study its effects on genome especially in In-
vivo condition. Metosartan doesn’t affect the chromatin integrity in hypertensive rats but reduces the sperm count drastically and 
reaches up to zero at 1.25mg/ml concentration. Majorly the drug affects the sperm count but not the maturation of sperm. In 
hypertension condition the sperms are aggregated in to complex where as in metosartan treated group In-vitro lead to severe looping 
of sperms and resulted in formation of apoptotic bodies. In normal rats excessive DNA fragmentation is seen in metosartan treated 
group and treatment with RNase A along with metosartan in-vitro restored the chromatin integrity but failed to give promisive 
results in In-vivo condition. So, study of genome integrity in hypertensive patients treated with metosartan is compulsory as it 
affects chromatin integrity adversely in In-vitro condition in normal rats.  
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INTRODUCTION 
Metosartan is normally used to treat hypertension but its 
effects on reproductive potential were not up to the 
mark. Angiotensin-II is the effector molecule that 
controls hypertension by acting via two types of 
receptors namely angiotensin receptor type I and 
angiotensin receptor type II. Angiotensin receptor typeI 
is expressed ubiquitously where as angiotensin type II 
expresses only in certain tissues. Metosartan mainly 
blocks the beta receptors on the heart and also 
angiotensin type I receptor.  In-vitro results of metosartan 
have confirmed the deleterious effects of metosartan on 
the testes and sperms. So, in vivo confirmation of results 
is necessary for the effective and safe medication of the 
drug. Normal sperm count ranges from 15 million to 
200 million sperms per ml of ejaculate.  Drugs like 
antidepressants, alpha adrenergic blockers and calcium 
channel blockers affect the sperm quality and sperm 
count 
1
.  
Metosartan is also one of the drugs that effects sperm 
count drastically in male wistar rats. However in human 
subjects it needs to be tested. Chromatin integrity is the 
main factor that is affected by drug metosartan in testes 
and sperms in invitro. Treatment with drug leads to 
apoptosis in rats by cyt C release from mitochondria 
2
.  
RNase A is the ribonuclease secreted by the pancreas 
and involved in digestion of RNA present in the food. It 
is very difficult to inactivate RNase A, so all the 
experiments are carried out at room temperature. 
 RNase A treatment lead to membrane dissolution and 
decondensation of chromatin in In-vitro 
3
. Recently a 
ribonuclear protein complex containing Rae 1 is proved 
to be necessary for mitotic spindle assembly. So, RNA 
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is not only part of the chromatin but also necessary for 
the activity of Rae 1 
4
. DNA fragmentation was 
profound in sperm than testes associated with 
metosartan treatment in hypertension induced rats. 
Azoospermia is the condition seen in hypertension 
induced rats kept under medication with metosartan at 
concentration greater than 1mg. Mitochondrial viability 
was unaffected with metosartan in rats compared to 
other parameters. But with RNaseA the mitochondrial 
viability was less and resulted in constant functioning in 
In-vivo at low concentrations. In B.P induced rats high 
sugar concentration leads to uncontrolled stress 
condition which may affect the mitochondria due to 
continuous operation of electron transport chain. This 
may leads to oxidative stress in these rats.  
Due to high sugar concentration and intermediary 
metabolism of sugars to fat there is large granulation of 
testes as it is involved in synthesis of gonadal harmones 
like testosterone. Various sperm abnormalities like 
teratozoospermia is associated with metosartan in both 
In-vitro and In-vivo conditions. However RNase A 
protection against chromosomal stability was known 
recently which removal of R loops which causes 
instability 
5
. Numbers of viable sperms are also found to 
be reduced in metosartan medicated rats invivo. 
However the metosartan affects the reproduction 
potential of the male rats in adverse manner and causes 
apoptosis in sperm and testes leading to male infertility. 
The objective of the study is mainly to study the effect 
of drug on genome integrity and reproductive potential 
of male rats during hypertension condition. 
MATERIAL AND METHODS 
Experimental design: 
Male wistar rats of body weight ranging between 250-
300g was divided in to three groups and administered 
with 10% fructose in drinking water to induce 
hypertension and monitored for 1 week. After 1 week 
the blood glucose levels are measured and recorded. 
After confirmation of hypertension induction in the rats 
metosartan commercially available of potential 25mg of 
metoprolol and telmisartan 45mg was administered 
orally with concentration of 500µg/ml followed by 
1mg/ml and 1.25 mg/ml in the alternate days to each 
animal in the group separately and one of the animal is 
sacrificed in the group on the next day and the 
experiments are performed. During the treatment period 
with metosartan the hypertension was maintained 
sustainly through 10% fructose. The animals are 
sacrificed after 1 day and sperm count, genome integrity 
assays and agarose gel electrophoresis of sperm samples 
were done accordingly. 
Genome integrity assays: 
Aniline blue staining: 
The protocol was followed as per  cited reference 
14 
with 
minor modifications which are briefly explained here. 
Five microliters of minced a testis suspension was 
placed on the glass slide, smear was made, air dried and 
fixed in 3%glutaraldehyde solution in 0.2M PBS of pH 
7.4 for 30 min. After the incubation of the slides with 
fixative they were stained with 5% acidic aniline blue 
stain (5g aniline blue in 100ml of 4% glacial acetic acid 
in double distilled water, pH 3.5) for 5 min, air dried 
and observed under the compound microscope at 10X x 
20. 
Comet assay: 
Standard comet assay as per cited reference 
15 100μl of 
the isolated mitochondria pellet was mixed with 1000μl 
of 0.8% agarose and 100μl of mixed suspension was 
spread on the slide and kept in ice for 45min. After 
casting, the slides were immersed in lysis buffer (2.5% 
SDS in 45 mM Tris–borate, 1 mM EDTA, pH 8.4) for 
20min and incubated in electrophoresis buffer for 5min. 
Electrophoresis was carried out with  45mM TBE buffer 
with pH 8.4 at 2v/cm for 2min and Ethidium bromide 
staining was performed and visualised using fluorescent 
microscope. 
Sperm count: 
Epididymis was dissected using sterile scissors and the 
sperms were collected by making 5 to 6 incisions on the 
epididymis up to the liquid becomes pale yellow and 
some portion of the liquid was transferred to neubar 
chamber which was previously adjusted using 
microscope and allowed to settle for 5min. sperms in the 
four chambers were counted and the sperm count was 
calculated. 
Isolation of DNA: 
The protocol was as per cited reference 
16
. Testes were 
homogenized in lysis buffer (50 mM Tris-Cl, pH 8.0, 
100 mM EDTA, 0.125% SDS) using mortar and pestle 
and further 1ml of the lysis buffer was added to the 
collected supernatant and incubated for overnight at 
55
0
C. To the lysate an ml of phenol: chloroform: 
isoamyl alcohol (25:24:1) mixture was added and 
centrifuged at 2000xg for 10min. Aqueous phase was 
collected and washed once again with  1ml of phenol: 
chloroform: isoamyl alcohol mixture and 3ml of 
chloroform. Aqueous phase was separated and DNA 
was precipitated with cold ethanol. Precipitated DNA 
was pelleted, collected and stored at -20
0
C.  
Agarose gel electrophoresis: 
1% agarose gel was prepared and the isolated sperm 
DNA was loaded in to respective wells along with 
loading buffer and the gel was run with 1X TBE buffer 
at standard conditions and examined under 
transilluminator after the run. 
Measurement of Glucose levels in blood: 
Blood glucose levels are measured by Glucometer and 
recorded in both test groups and control. 
RESULTS 
In-vitro effects of drug metosartan and RNase A on 
testes and sperm: 
From the figure 1 Control appears normal where as 
RNase A treatment resulted in aggregation and 
acrosome reacted sperms where as with both RNase A 
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and drug treated samples sperms are not visible in short 
term changes. From figure 1C and 1G Drug treated and 
M+R treated sample with short term changes is 
associated with similar consistency of chromatin as that 
of control. From figure 1D the chromosomes showed 
abnormal synapsis of X-chr 
6
. Drug treated sample 
consists of mixture of both immature and mature sperms 
where as in drug+ RNase A treated sample consists of 
more number of immature sperms. 
   
 
Figure 1: Short term and long term changes associated with sperm samples treated with metosartan and RNase A In-vitro. (A), (B) 
are control of short term changes and long term changes (C ), (D) are short term changes and long term changes associated with 
Drug treated sample (E ), (F) are short term and long term changes associated with RNase A treated sample (G), (H) are short term 
and Long term changes associated with both drug and RNase A treated sample In (E) 1 indicates aggregation of sperms and 2 
indicates acrosome reacted sperm. In (F) 2 indicates abnormal sperm and 1 indicates looped sperm. In (H) 1 indicates interlinked 
sperms. In 1D the arrow mark shows abnormal synapsis of X chromosome. 
From figure 2B control appeared normal with 
nucleosome the basic unit of chromatin and drug treated 
sample with apoptotic bodies and teratozoospermia, 
where as figure 2F showed condensed chromosomes 
which explains the involvement of Rae 1 containing 
ribonucleoprotein in spindle assembly which requires 
RNA for its activity 
4
. During the time gap between the 
study of short term changes and long term changes 
associated with sample the chromatin condensed in to 
chromosomes but consisting of abnormally separated 
sister chromatids.  Whereas in figure 2H the RNase A + 
drug treated group showed reorganisation of chromatin 
as drug binds and inhibits RNase A so, the enzyme is 
not released and drug induced effects are also minimal. 
In 2D the drug treated sample showed severe looping of 
sperms and resulted in formation of apoptotic bodies. 
 
 
Figure 2: Short term and Long term changes in testes treated with drug and RNase A in vitro. (A)  Short term control (B) long term 
control showing chromatin arranged as nucleosomes which is indicated by arrows.  (C) Short term changes associated with drug 
treated sample (D) long term changes associated with drug treated sample (E) Short term changes associated with RNase A treated 
sample. (F) Long term changes associated with RNase A treated sample. (G) Short term changes associated with Drug + RNase A 
treated group (H) long term changes associated with Drug + RNase A treated group which showed reappearance of chromatin 
network. In 1(G) the Drug + RNase A  and 1 (C ) the drug treated samples showed similar consistency with control where as  in 1(E 
) RNase A treatment lead to cleavage of chromatin. 
 
Beeram Eswari                                                                                                 Journal of Drug Delivery & Therapeutics. 2018; 8(5):400-406           
ISSN: 2250-1177                                                                             [403]                                                                             CODEN (USA): JDDTAO 
In-vivo effects of drug metosartan and RNase A on 
testes of normal and hypertension induced rats: 
In figure 3 (A) 1 indicates chromatin basic unit 
nucleosome. Epigenetic mechanisms like histone 
modification and DNA methylation in CpG islands and 
involvement of miRNAs are known to be occur during 
B.P 
7
 and miRNA 425 correlates positively with B.P 
clearly indicates the role of noncoding RNAs in gene 
regulation pathways during hypertension
8
. From figure 3 
Hypertension induced control showed normal 
appearance of chromatin but higher order structures are 
not found. In in-vivo condition drug treated sample 
showed extensive DNA fragmentation where as 1E 
shows normal sperm structure but with immature sperms 
and less DNA fragmentation. 1D, 1F and1G showed 
normal chromatin except in 1mg treated rats. 
 
 
Figure 3: In-vivo effects of drug metosartan and RNase A in normal and hypertension induced rats treated with metosartan. (A) 
Control of testes of normal rats (B) control of testes in hypertension induced rats. (C) In-vivo drug treated rats at concentration 
100µg in normal rats  (D) In-vivo drug treated sample at concentration 1.25mg of metosartan in hypertension induced rats (E ) In-
vivo RNase A+ metosartan treated sample at concentration 100 µg in normal rats. (F) In-vivo drug treated sample of concentration 
500 µg of metosartan in hypertension induced rats. (G) In-vivo drug treated sample of concentration 1mg of metosartan in 
hypertension induced rats. 
In-vivo effects of drug metosartan on sperms of 
hypertension induced rats: 
From figure 4B the B.P control showed aggregation of 
sperms in to complex and sperms treated with low doses 
of metosartan doesn’t affected the maturation and as 
flagellum consists of axoneme which is made up of 
tubulin complex is also observed in sperm tail 
9
. From 
figure 4D Metosartan causes complement mediated 
activation of cell death also in addition to apoptosis 
which is evident by the presence of complement 
regulatory factors CD55, CD46, CD59, C1-INH on 
sperm surface 
10
. In spite of their presence they does not 
protect the sperm from C-mediated injury. Treatment of 
rats with metosartan at concentration of 1.25mg/ml 
resulted in aspermatogonia. 
  
 
Figure 4: In-vivo effects of drug metosartan on sperms of hypertension induced rats. (A) control (B) Control of hypertension induced 
rats (C ) sperms of hypertension induced rats treated with metosartan of concentration 500 µg/ml (D) sperms of hypertension 
induced rats treated with metosartan of concentration 1mg/ml and (E) sperms of hypertension induced rats treated with metosartan of 
concentration1.25mg/ml. 
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Figure 5: Assessment of genome integrity in testes of normal and hypertension induced rats by comet assay. (A) comet assay of 
sperm sample treated with metosartan at concentration of 500 µg/ml. comets were observed which indicates DNA fragmentation in 
the nucleus of the sperm. (B) Study of comets at concentration of 1mg/ml of metosartan. Most of the cells are normal and DNA 
fragmentation was normal compared to low dose of metosartan. (C) Examination of sperm by comet assay at concentration of 
1.25mg/ml of metosartan. DNA fragmentation and ds breaks are absent at higher concentration. (D) Comet assay of testes in normal 
rats treated with 100 µg/100µl of metosartan. (E) Testes of hypertension induced rats at concentration 500 µg/ml. (F) Testes of 
hypertension induced rats at concentration of1mg/ml of metosartan (G) Testes of hypertension induced rats with no ds breaks at 
concentration of 1.25 mg/ml of metosartan. (H) Comet assay of control testes. 
 
Comet assay of sperm and testes of normal and 
hypertension induced rats treated with metosartan: 
Except at low dose of metosartan in normal and 
hypertension induced rats all the sperm and testes 
samples showed normal genome integrity without any 
DNA fragmentation which is further supported by 
agarose gel run of sperm samples from figure 6. From 
figure 6 S1 showed maximum DNA fragmentation 
compared to S2 and S3. Sperm count was increased with 
increase in dosage of metosartan but it resulted in 
aspermatogonia at higher concentrations of drug. 
Glucose levels are found to be normal in control but in 
hypertension induced rats it is drastically increased up to 
427mg/dl.
 
 
Figure 6:   Agarose gel electrophoresis of   In-vivo treated sperm samples with metosartan at 500 µg/ml (S1), 1mg/ml (S2) and 
1.25mg/ml (S3). DNA fragmentation was more in S1 compared to S2 and S3. 
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Table 1: Semen parameters in normal and hypertension induced rats. In metosartan (1.25mg/ml) treated group aspermatogonia is 
observed both in testes and epididymis. In normal rats metosartan treated group was observed with highest sperm count and viability 
compared with metosartan+ RNase A treated group. (-) represents experiments not performed. 
 Sperm count in normal rats 
treated with metosartan at 
concentration of 100 µg/100µl 
No. of viable sperms in 
normal rats treated 
with100 µg/100µl of 
metosartan 
Sperm count in hypertension 
induced rats  at three different 
concentrations 
Metosartan group 11,02500sperms /ml 10,10,000 viable 
sperms /ml 
- 
Metosartan + RNase 
A treated group 
1,20,000 sperms/ml 
 
1,20,000 viable  sperms 
/ml 
- 
Metosartan treated 
group of conc. 500 
µg/1ml 
- - 1,0000,000 sperms/ml 
Metosartan treated 
group of conc. 
1mg/1ml 
- - 1,92,80,000 sperms/ml 
Metosartan treated 
group of conc. 
1.25mg/ml 
- - 0 sperms/ml 
 
 
Figure 7:  Glucose concentration in hypertension induced rats (mg/dl). Control consists of 82mg/dl concentration of glucose in blood 
where as highest glucose concentration was recorded in 5th rat with glucose concentration ranging in between 400-450 mg/dl. 
DISCUSSION 
Hypertension is one of the long term medical condition 
characterised by high blood pressure. So, the risk of the 
death due to hypertension can be avoided by changing 
lifestyle of the person. If the hypertension cannot be 
controlled by lifestyle, medications that reduce blood 
pressure is found to be useful. Metosartan is one of such 
antihypertensive drug that includes two active 
components telmisartan and metoprolol. Telmisartan has 
been found to be involved in various protective effects 
but when given in combination as metosartan with 
metoprolol it resulted in deleterious effects like 
apoptosis, complement activation, loss of chromatin 
integrity. However in hypertensive rats chromatin 
integrity was maintained eventhough after In-vivo 
treatment with metosartan but the reproductive potential 
of the male rats are severely compromised at higher 
concentrations of drug. Sperm genome was highly 
fragmented even at low concentrations of drug.  
Assays that detect abnormal genome integrity like comet 
assay showed normal results and the drug doesn’t affect 
maturation of sperms invivo. Sperm count and sperm 
motility was drastically compromised in metosartan 
treated rats invivo. In humans chr 1q is the loci 
associated with B.P similar to mouse and rat B.P loci 
associated with alterations in three genes namely 
ATP1B1, RGSS and SELE 
11
. Individuals with defects 
in genes leads to reduction in cumulative systolic BPs 
ranging between 8-10mm Hg 
11
 . B.P is mainly due to 
defects in pathways that regulate the hypertension. 
However the pathways which is acted up on by 
metosartan include alpha and beta receptors on caronary 
arteries and Renin-Angiotensin system that regulates 
blood pressure.Other pathways related to BP is 
production of Hexadecanedioate by secondary fattyacid 
oxidative pathway 
12
. The compound effect is related to 
increase in intracellular levels compared to circulating 
levels 
12
. 
Glucose levels, triglycerides and plasma insulin levels 
are mainly elevated in blood pressure 
13 
in present 
context it reached up to 400-450mg/dl. In normal rats 
treatment with metosartan leads to apoptosis through 
release of cytochrome C and induction of ds DNA 
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breaks in the genome. In-vitro effects are more 
deleterious compared to In-vivo results as the testicular 
system is directly exposed to drug and due to lack of 
counteracting mechanisms. In normal rats the treatment 
of RNase along with metosartan lead to further decrease 
in sperm count compared to metosartan treated group.  
Together the use of metosartan effects with respect to 
high concentration in BP patients should be monitored 
carefully otherwise which may leads to loss of 
reproductive potential in male subjects. The effects are 
temporary or permanent should also be kept in mind. 
CONCLUSION 
Telmisartan one of the active agent in the drug 
metosartan induces ds DNA breaks in the genome and 
metoprolol known to effect semen parameters .so, it is 
necessary to study the effect of two as the combined 
agent metosartan to know the drug- drug interactions. 
Metosartan effect on male reproductive potential was 
adverse with azoospermia and teratozoospermia in the 
hypertensive rats and eventhough it doesn’t effect the 
maturation, it does it in synthesis of sperms in 
testes.Treatment of rats along with metosartan and 
RNase A resulted in restoration of chromatin integrity it 
failed incase of In-vivo condition in normal rats. 
Genome integrity was not affected in hypertension 
induced rats compared to normal rats. Together the drug 
effects the sperm count, sperm viability and testes 
viability in normal rats where as it affects sperm count 
especially in hypertensive rats leading to azoospermia 
and abnormal synapsis of X-chr in male rats induced 
with hypertension. 
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